A flowchart that shows the process of the ARX-01 Sublingual Sufentanil Patient-Controlled Analgesia (PCA) system. The flowchart is divided into four sections each representing a different stage of the system.
The first section is labeled "Inpatient Acute Postoperative Pain" and shows an illustration of a person's hand holding a syringe. The second section is titled "ARX-02: Sufentanil NanoTab BTP Management System". The third section is labeled "Cancer Breakthrough Pain (BTP)". The fourth section is called "Rapid-Onset Sublingual Sufentail Triazolam NanoTab" and has a description of the process. The fifth section has a list of market advantages and market advantages including improved patient mobility no IV complications and no programming errors. The sixth section has an explanation of the risks associated with the system including rapid onset of action safe-minimal monitoring requirements and a sedation for office-based procedures. The seventh section has the title "Sedation for Office-Based Procedures" and a brief description of how the system works.
Type
Category
Source 1 of 2
-
Date
2008
Collection
-
Date
2008
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.